Singapore, Sept. 1 -- SHIRE ACQUISITIONS INVESTMENTS IRELAND DESIGNATED ACTIVITY COMPANY made the following announcement:
Security Name: NA
General Announcement::U.S. Food and Drug Administration approval of the New Drug Application for MIMRYLO (rusfertide) (https://links.sgx.com/1.0.0/corporate-announcements/PX74DOJV4FJJAOQS/1a74f7a9ae8d0ffc5b2dce2e8a9b1337c60cab08eb7be33b9cc1751c0bbf2a8c)
Published by HT Digital Content Services with permission from South East Asian News....